IPO GMP Today — August 27, 2026
The Indian IPO market is seeing strong investor activity today, with several public issues attracting attention in the grey market.
Among the most discussed IPOs are Hy-Tech Engineers, Lumino Industries, Symbiotec Pharmalab, Skyways Air Services and Annu Projects.
The biggest talking point is Hy-Tech Engineers, where the grey market premium has climbed sharply. Meanwhile, Lumino Industries opened for subscription today with a GMP indicating a potentially strong listing.
Important: GMP, or Grey Market Premium, is unofficial and can change quickly. It is not a guarantee of the actual listing price or returns.
IPO GMP Today: Quick Overview
| IPO | Price Band | GMP* | Indicative Listing Price | Approx. GMP |
|---|---|---|---|---|
| Hy-Tech Engineers | ₹50–₹53 | ₹44–₹45 | ~₹97–₹98 | ~83–85% |
| Lumino Industries | ₹78–₹82 | ~₹55–₹56 | ~₹137–₹138 | ~67–68% |
| Kwick Forensic Solutions | ₹85–₹90 | ~₹64 | ~₹154 | ~71% |
| Symbiotec Pharmalab | ₹938–₹988 | ~₹285 | ~₹1,273 | ~29% |
| Skyways Air Services | ₹131–₹138 | ~₹42–₹46 | ~₹180–₹184 | ~30–33% |
| Annu Projects | ₹94–₹99 | ~₹4–₹6 | ~₹103–₹105 | ~4–6% |
*GMP figures can vary between sources and during the day. The figures above reflect reported grey-market levels on August 27, 2026.
1. Hy-Tech Engineers IPO GMP Today
Hy-Tech Engineers is currently the strongest GMP story among the major IPOs being tracked today.
The IPO has a price band of ₹50 to ₹53 per share. The latest reported GMP is around ₹44–₹45, implying a potential listing price near ₹97–₹98 if the grey-market premium holds.
That translates into an implied listing premium of roughly 83–85% over the upper price band.
Subscription is extremely strong
The IPO has attracted enormous demand on its final day.
By the afternoon, reports showed subscription running above 200 times, while later NSE data indicated the issue eventually closed at around 244 times subscription.
The IPO opened on August 24 and closes on August 27. The tentative listing date is September 1, 2026.
What does Hy-Tech Engineers do?
Hy-Tech Engineers manufactures hydraulic fittings and related components.
Its products are used in areas such as:
- Construction equipment
- Automobiles
- Agricultural machinery
- Injection moulding
- Hydraulic systems
- Industrial machinery
The company has been operating in the hydraulics industry for more than four decades.
Why is the IPO attracting attention?
The combination of:
Strong subscription + rising GMP + relatively small issue size
has created significant investor interest.
However, an 80%+ GMP should not automatically be interpreted as an 80% guaranteed return.
2. Lumino Industries IPO GMP Today
Lumino Industries is the other IPO attracting considerable attention today.
The ₹700 crore IPO opened for subscription on August 27 and will remain open until August 31, 2026.
The price band has been fixed at ₹78–₹82 per share.
The latest reported GMP is around ₹55–₹56.
At a GMP of ₹56:
₹82 + ₹56 = ₹138
That gives an indicative listing price of approximately ₹138, or around 68% above the upper issue price.
Earlier reports during the day showed GMP around ₹50–₹51, indicating that grey-market sentiment strengthened as trading progressed.
What does Lumino Industries do?
Lumino Industries operates in the electrical conductors, wires and cables segment.
The company is looking to raise around ₹700 crore through the IPO.
One of the key objectives is to use the IPO proceeds for debt reduction and expansion of manufacturing capacity.
This makes Lumino particularly interesting because the IPO isn’t simply an offer for existing shareholders to sell their holdings—the company is also looking to strengthen its balance sheet and expand its business.
3. Symbiotec Pharmalab IPO GMP
Another major IPO currently attracting attention is Symbiotec Pharmalab.
Its price band is ₹938–₹988 per share.
The latest reported GMP is around ₹285, implying a potential listing price of approximately:
₹988 + ₹285 = ₹1,273
That represents a potential premium of roughly 29% over the upper price band.
The IPO has also attracted strong subscription demand.
Symbiotec operates in the pharmaceutical and biotechnology sector.
The company plans to use part of the IPO proceeds to repay or prepay certain borrowings, with around ₹112.5 crore earmarked for this purpose.
4. Skyways Air Services IPO GMP
Skyways Air Services is another IPO investors are watching closely.
The issue has a price band of ₹131–₹138.
Current GMP estimates are around ₹42–₹46, implying a potential listing premium of roughly 30–33%.
Compared with Hy-Tech Engineers and Lumino Industries, the implied GMP is lower, but it still indicates positive grey-market sentiment.
5. Annu Projects IPO GMP
Annu Projects is currently showing a much more modest GMP.
The price band is ₹94–₹99, while the latest reported GMP is approximately ₹4–₹6.
That suggests an indicative listing price around ₹103–₹105, representing roughly 4–6% potential premium over the upper price band.
The IPO closes on August 28.
Compared with Hy-Tech Engineers and Lumino Industries, the grey-market enthusiasm is considerably lower.
Which IPO Has the Highest GMP Today?
Based on reported GMP levels on August 27:
🥇 Hy-Tech Engineers
GMP: ~₹44–₹45
Potential premium: ~83–85%
🥈 Kwick Forensic Solutions
GMP: ~₹64
Potential premium: ~71%
🥉 Lumino Industries
GMP: ~₹55–₹56
Potential premium: ~67–68%
Other notable IPOs
Skyways Air Services: ~30–33%
Symbiotec Pharmalab: ~29%
Annu Projects: ~4–6%
What Does GMP Actually Mean?
GMP stands for Grey Market Premium.
It represents the premium at which an IPO share is reportedly being traded in the unofficial grey market before its stock-market listing.
For example:
If an IPO’s upper price is:
₹82
and GMP is:
₹56
then the estimated listing price is:
₹82 + ₹56 = ₹138
The implied gain is:
₹56 ÷ ₹82 × 100 ≈ 68%
But this is only an indication, not a prediction.
The actual listing price can be significantly different.
Why Can GMP Be Misleading?
GMP is not regulated like the official stock market.
It can change because of:
- Market sentiment
- IPO subscription numbers
- Demand from investors
- Broader market conditions
- News about the company
- Expected listing demand
- Last-minute buying or selling
Therefore, a high GMP does not guarantee a high listing gain.
For example, an IPO can have a strong GMP before listing and still open below the grey-market expectation.
Hy-Tech Engineers vs Lumino Industries
If we compare the two IPOs that are getting the most attention today:
| Factor | Hy-Tech Engineers | Lumino Industries |
|---|---|---|
| Price Band | ₹50–₹53 | ₹78–₹82 |
| IPO Size | ~₹136 crore | ₹700 crore |
| GMP | ~₹44–₹45 | ~₹55–₹56 |
| Implied Premium | ~83–85% | ~67–68% |
| Subscription | Extremely strong | Just opened |
| Sector | Hydraulic components | Wires & cables |
| IPO Status | Closes Aug 27 | Open Aug 27–31 |
| Indicative Listing | ~₹97–₹98 | ~₹137–₹138 |
Hy-Tech Engineers currently has the stronger GMP percentage, while Lumino Industries has a substantially larger issue size and is only at the beginning of its subscription period.
What Investors Should Watch Next
For investors tracking these IPOs, the next important indicators are:
- Final subscription numbers
- QIB subscription
- Retail subscription
- GMP movement before listing
- IPO allotment
- Market conditions on listing day
- Company fundamentals and valuation
The GMP can change substantially between the IPO closing date and listing date.
Bottom Line
Hy-Tech Engineers is currently the standout IPO on GMP, with grey-market indications pointing to a potential premium of more than 80%.
Lumino Industries is also generating significant interest, with GMP indicating a potential listing premium of around 67–68%.
Symbiotec Pharmalab and Skyways Air Services are showing more moderate but still positive GMP signals, while Annu Projects is showing a much smaller premium.
The important point is that GMP is only a sentiment indicator—not a guaranteed return. Investors should also examine the company’s business, financial performance, valuation, debt, growth prospects and the purpose of the IPO proceeds before making an investment decision.
Disclaimer: This article has been prepared with the help of AI using publicly available information and news reports available on August 27, 2026. GMP figures are unofficial and can change rapidly. The information is provided only for educational and informational purposes and should not be considered investment, financial or securities advice. Investors should conduct their own research or consult a qualified financial adviser before investing.
